AMENDMENT dated May 1, 2019 to that MEMORANDUM OF AGREEMENT executed on October 1, 2014 and effective July 15, 2014 ("Amendment").IntelGenx Technologies Corp. • May 9th, 2019 • Pharmaceutical preparations
BETWEEN INTELGENX CORP., a corporation constituted under the law of Canada, having its head office at 6425 Abrams, Ville St.-Laurent, Quebec H4S 1X9 duly represented by John Marinucci, Chair of the Compensation Committee duly authorized to do so as he declares
AMENDMENT dated May 6, 2019 to that MEMORANDUM OF AGREEMENT executed on March 1, 2016 ("Amendment").Memorandum of Agreement • May 9th, 2019 • IntelGenx Technologies Corp. • Pharmaceutical preparations
BETWEEN INTELGENX CORP., a corporation constituted under the law of Canada, having its head office at 6420 Abrams, Ville St.-Laurent, Quebec H4S 1X9 duly represented by Dr. Horst Zerbe, its CEO and President, duly authorized to do so as he declares
AMENDMENT dated May 1st, 2019 to that MEMORANDUM OF AGREEMENT executed on July 20, 2015 ("Amendment").Memorandum of Agreement • May 9th, 2019 • IntelGenx Technologies Corp. • Pharmaceutical preparations
BETWEEN INTELGENX CORP., a corporation constituted under the law of Canada, having its head office at 6420 Abrams, Ville St.-Laurent, Quebec H4S 1X9 duly represented by Dr. Horst Zerbe, its CEO and President, duly authorized to do so as he declares
AMENDMENT dated May 6, 2019 to that MEMORANDUM OF AGREEMENT executed on January 19, 2016 ("Amendment").Memorandum of Agreement • May 9th, 2019 • IntelGenx Technologies Corp. • Pharmaceutical preparations
BETWEEN INTELGENX CORP., a corporation constituted under the law of Canada, having its head office at 6420 Abrams, Ville St.-Laurent, Quebec H4S 1X9 duly represented by Dr. Horst Zerbe, its CEO and President, duly authorized to do so as he declare
